SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Cannabis Sativa, Inc. (CBDS) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 24/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
25/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CBDS
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio6.06
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.18 |
$29.17K |
$-3.13M |
-10741.2% |
| 2017 |
$-0.38 |
$317.99K |
$-7.56M |
-2378.7% |
| 2018 |
$-0.20 |
$505.71K |
$-4.13M |
-816.3% |
| 2019 |
$-0.18 |
$1.16M |
$-3.94M |
-339.3% |
| 2020 |
$-0.09 |
$1.94M |
$-2.17M |
-112% |
| 2021 |
$-0.09 |
$1.84M |
$-2.45M |
-132.9% |
| 2022 |
$-0.03 |
$1.56M |
$-1.22M |
-77.9% |
| 2023 |
$-0.03 |
$1.17M |
$-1.39M |
-118.6% |
| 2024 |
$-0.02 |
$802.7K |
$-1.73M |
-215.5% |
| 2025 |
$0.00 |
$738.91K |
$-573.39K |
-77.6% |
